These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8211875)

  • 1. Phospholipid content of bronchoalveolar lavage fluid in granite workers with silicosis in Quebec.
    Bégin R; Lesur O; Bouhadiba T; Guojian L; Larivée P; Melloni B; Martel M; Cantin A
    Thorax; 1993 Aug; 48(8):840-4. PubMed ID: 8211875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospholipid concentration in lung lavage fluid as biomarker for pulmonary fibrosis.
    Kuroda K; Morimoto Y; Ogami A; Oyabu T; Nagatomo H; Hirohashi M; Yamato H; Nagafuchi Y; Tanaka I
    Inhal Toxicol; 2006 May; 18(5):389-93. PubMed ID: 16513595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factor-alpha alters phospholipid content in the bronchoalveolar lavage-accessible space of isolated perfused rat lungs.
    Hertzog JH; Godinez MH; Godinez RI
    Crit Care Med; 1994 Dec; 22(12):1969-75. PubMed ID: 7988135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic pulmonary fibrosis. Abnormalities in bronchoalveolar lavage fluid phospholipids.
    Robinson PC; Watters LC; King TE; Mason RJ
    Am Rev Respir Dis; 1988 Mar; 137(3):585-91. PubMed ID: 3345040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T lymphocytes and silica-induced pulmonary inflammation and fibrosis in mice.
    Suzuki N; Ohta K; Horiuchi T; Takizawa H; Ueda T; Kuwabara M; Shiga J; Ito K
    Thorax; 1996 Oct; 51(10):1036-42. PubMed ID: 8977606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Extracellular components of broncho-alveolar lavage fluid (BALF) as markers of interstitial pulmonary disease activity. II. Phospholipid concentration].
    Zielonka TM; Wałajtys-Rode E; Jasińska R; Chazan R; Droszcz W
    Przegl Lek; 1998; 55(12):654-8. PubMed ID: 10354716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quartz exposure, retention, and early silicosis in sheep.
    Bégin R; Dufresne A; Cantin A; Possmayer F; Sébastien P; Fabi D; Bilodeau G; Martel M; Bisson D; Pietrowski B
    Exp Lung Res; 1989 May; 15(3):409-28. PubMed ID: 2545436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic pulmonary fibrosis. Abnormalities in the bronchoalveolar lavage content of surfactant protein A.
    McCormack FX; King TE; Voelker DR; Robinson PC; Mason RJ
    Am Rev Respir Dis; 1991 Jul; 144(1):160-6. PubMed ID: 2064123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental studies on the therapeutic effects of lung lavage with large volume of saline on silicosis].
    Zhang H; Li Q; Yao R; Guo N
    Wei Sheng Yan Jiu; 1997 Mar; 26(2):77-9. PubMed ID: 10325605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung alkaline phosphatase as a marker of fibrosis in chronic interstitial disorders.
    Capelli A; Lusuardi M; Cerutti CG; Donner CF
    Am J Respir Crit Care Med; 1997 Jan; 155(1):249-53. PubMed ID: 9001320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of bronchoalveolar lavage fluid phospholipids and cytokine release by alveolar macrophages as prognostic markers in sarcoidosis.
    Tahanovich AD; Katovich IL; Baradzina HL
    Respiration; 2003; 70(4):376-81. PubMed ID: 14512673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronic acid in bronchoalveolar lavage fluid in patients with sarcoidosis: relationship to lavage mast cells.
    Bjermer L; Engström-Laurent A; Thunell M; Hällgren R
    Thorax; 1987 Dec; 42(12):933-8. PubMed ID: 3438882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYFRA 21-1, a cytokeratin subunit 19 fragment, in bronchoalveolar lavage fluid from patients with interstitial lung disease.
    Kanazawa H; Yoshikawa T; Yamada M; Shoji S; Fujii T; Kudoh S; Hirata K; Yoshikawa J
    Clin Sci (Lond); 1998 May; 94(5):531-5. PubMed ID: 9682677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in phospholipids in bronchoalveolar lavage fluid of patients with interstitial lung diseases.
    Honda Y; Tsunematsu K; Suzuki A; Akino T
    Lung; 1988; 166(5):293-301. PubMed ID: 3146676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of work exposure, retirement, and smoking on bronchoalveolar lavage measurements of lung dust in Vermont granite workers.
    Christman JW; Emerson RJ; Hemenway DR; Graham WG; Davis GS
    Am Rev Respir Dis; 1991 Dec; 144(6):1307-13. PubMed ID: 1660228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme activities of lung lavage in silicosis.
    Larivée P; Cantin A; Dufresne A; Bégin R
    Lung; 1990; 168(3):151-8. PubMed ID: 2114508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein macroaggregates in bronchoalveolar lavage fluid from patients with diffuse interstitial lung disease: comparison with idiopathic alveolar lipoproteinosis.
    Haslam PL; Hughes DA; Dewar A; Pantin CF
    Thorax; 1988 Feb; 43(2):140-6. PubMed ID: 3353885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased procollagen III aminoterminal peptide-related antigens and fibroblast growth signals in the lungs of patients with idiopathic pulmonary fibrosis.
    Cantin AM; Boileau R; Bégin R
    Am Rev Respir Dis; 1988 Mar; 137(3):572-8. PubMed ID: 3345038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of Talc (CAS No. 14807-96-6)(Non-Asbestiform) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 421():1-287. PubMed ID: 12616290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amiodarone-induced pulmonary toxicity. Immunoallergologic tests and bronchoalveolar lavage phospholipid content.
    Nicolet-Chatelain G; Prevost MC; Escamilla R; Migueres J
    Chest; 1991 Feb; 99(2):363-9. PubMed ID: 1989796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.